Radiobiological evaluation and correlation with the local effect model (LEM) of carbon ion radiation therapy and temozolomide in glioblastoma cell lines

被引:64
作者
Combs, Stephanie E. [1 ]
Bohl, Jessica [2 ]
Elsaesser, Thilo [2 ]
Weber, Klaus-Josef
Schulz-Ertner, Daniela
Debus, Juergen
Weyrather, Wilma K. [2 ]
机构
[1] Univ Heidelberg, Dept Radiat Oncol, Neuroradiat Oncol Res Grp, D-69120 Heidelberg, Germany
[2] Gesell Schwerionenforsch GSI, Darmstadt, Germany
关键词
Human glioma cells; temozolomide; carbon ion radiotherapy; relative biological effectiveness (RBE); MALIGNANT GLIOMA-CELLS; IN-VITRO; ANTITUMOR IMIDAZOTETRAZINES; ADVANCED CANCER; P53; STATUS; PHASE-I; RADIOTHERAPY; IRRADIATION; AGENT; BEAMS;
D O I
10.1080/09553000802641151
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose: To investigate the cytotoxic effect of high linear-energy transfer (LET) carbon irradiation on glioblastoma cells lines in combination with temozolomide (TMZ). Methods and materials: The cell lines U87-MG expressing wild-type p53 and LN229 expressing both mutant and wild-type p53 were irradiated with monoenergetic carbon ion beams (LET 172keV/m) or an extended Bragg peak (LET 103keV/m) after treatment with 10M or 20M TMZ. Cytotoxicity was measured by a clonogenic survival assay, and cell growth as well as cell cycle progression, were examined. Results: The p53 mutant was more sensitive to X-ray irradiation than the p53 wild type cell line, which was also expressed in a shorter G2 block. High LET carbon ions show an increased biological effectiveness in both cell lines, which is consistent with the predictive calculations by the Local Effect Model (LEM) introduced by Scholz et al. The cell line LN229 was more sensitive to TMZ treatment than the U87MG cell line expressing wild-type p53 only. The combination of TMZ and irradiation showed an additive effect in both cell lines. Conclusion: High LET carbon ion irradiation is significantly more effective for glioblastoma cell lines compared to photon irradiation. An additional treatment with TMZ may offer a great chance especially for several tumor types.
引用
收藏
页码:126 / 137
页数:12
相关论文
共 48 条
  • [1] Combined radiation and p53 gene therapy of malignant glioma cells
    Badie, B
    Goh, CS
    Klaver, J
    Herweijer, H
    Boothman, DA
    [J]. CANCER GENE THERAPY, 1999, 6 (02) : 155 - 162
  • [2] Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
    Bower, M
    Newlands, ES
    Bleehen, NM
    Brada, M
    Begent, RJH
    Calvert, H
    Colquhoun, I
    Lewis, P
    Brampton, MH
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 40 (06) : 484 - 488
  • [3] O(6)-METHYLGUANINE IN DNA INHIBITS REPLICATION IN-VITRO BY HUMAN CELL-EXTRACTS
    CECCOTTI, S
    DOGLIOTTI, E
    GANNON, J
    KARRAN, P
    BIGNAMI, M
    [J]. BIOCHEMISTRY, 1993, 32 (49) : 13664 - 13672
  • [4] Combs SE, 2005, STRAHLENTHER ONKOL, V181, P372, DOI 10.1007/s00066-005-1359-x
  • [5] Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens
    Combs, Stephanie E.
    Wagner, Johanna
    Bischof, Marc
    Welzel, Thomas
    Edler, Lutz
    Rausch, Renate
    Wagner, Florian
    Bois, Angelika Zabel-Du
    Debus, Juergen
    Schulz-Ertner, Daniela
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (04): : 999 - 1005
  • [6] In vitro responsiveness of glioma cell lines to multimodality treatment with radiotherapy, temozolomide, and epidermal growth factor receptor inhibition with cetuximab
    Combs, Stephanie E.
    Schulz-Ertner, Daniela
    Roth, Wilfried
    Herold-Mende, Christel
    Debus, Juergen
    Weber, Klaus-Josef
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (03): : 873 - 882
  • [7] Cluster effects within the local effect model
    Elsaesser, Thilo
    Scholz, Michael
    [J]. RADIATION RESEARCH, 2007, 167 (03) : 319 - 329
  • [8] Phase I study of temozolomide in paediatric patients with advanced cancer
    Estlin, EJ
    Lashford, L
    Ablett, S
    Price, L
    Gowing, R
    Gholkar, A
    Kohler, J
    Lewis, IJ
    Morland, B
    Pinkerton, CR
    Stevens, R
    Mott, M
    Stevens, R
    Newell, DR
    Walker, D
    Dicks-Mireaux, C
    McDowell, H
    Reidenberg, P
    Statkevich, P
    Marco, A
    Batra, V
    Dugan, N
    Pearson, ADJ
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 (05) : 652 - 661
  • [9] MAGNETIC SCANNING SYSTEM FOR HEAVY-ION THERAPY
    HABERER, T
    BECHER, W
    SCHARDT, D
    KRAFT, G
    [J]. NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 1993, 330 (1-2) : 296 - 305
  • [10] O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells
    Hermisson, M
    Klumpp, A
    Wick, W
    Wischhusen, J
    Nagel, G
    Roos, W
    Kaina, B
    Weller, M
    [J]. JOURNAL OF NEUROCHEMISTRY, 2006, 96 (03) : 766 - 776